TBRIF

Therma Bright Inc

As healthcare systems continue shifting toward outpatient care and at-home recovery, demand is rising for technologies that improve patient outcomes beyond the hospital setting. From post-surgical recovery to vascular health management, providers are increasingly prioritizing mobile, patient-compliant solutions that can extend care into everyday environments.Shares of Therma Bright Inc. (TSX-V: THRM) (OTCQB: TBRIF) are in focus Tuesday after the company announced a new strategic commercial partnership with Horizon Health, a U.S.-based provider of durable medical equipment with deep ties to ...

Therma Bright’s stock surges as its Venowave VW5 device secures a crucial Medicare and Medicaid designation, entering the $1.5B DVT market. With a strategic distribution partnership, Therma Bright is poised for rapid growth in medical devices and therapies.

Therma Bright’s stock surges as its Venowave VW5 device secures a crucial Medicare and Medicaid designation, entering the $1.5B DVT market. With a strategic distribution partnership, Therma Bright is poised for rapid growth in medical devices and therapies.

Therma Bright (TSXV: THRM) secures permanent Medicare and Medicaid reimbursement codes for its Venowave VW5 device, making it the only DVT treatment with such codes. This innovation has driven significant stock gains, with shares rising over 800% since May 2024.